Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer
Date
2019-11
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Ponnusamy, S, He, Y, Hwang, D-J, Thiyagarajan, T, Houtman, R, Bocharova, V, Sumpter, B G, Fernandez, E, Johnson, D, Du, Z, Pfeffer, L M, Getzenberg, R H, McEwan, I J, Miller, D D & Narayanan, R 2019, 'Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer', Clinical Cancer Research, vol. 25, no. 22, pp. 6764-6780. https://doi.org/10.1158/1078-0432.CCR-19-1458